CILLONI, Daniela
CILLONI, Daniela
SCIENZE CLINICHE E BIOLOGICHE
A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia
2019-01-01 Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco
A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia
2019-01-01 Bernardoni, Roberto; Giordani, Giorgia; Signorino, Elisabetta; Monticelli, Sara; Messa, Francesca; Pradotto, Monica; Rosso, Valentina; Bracco, Enrico; Giangrande, Angela; Perini, Giovanni; Saglio, Giuseppe; Cilloni, Daniela
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms
2017-01-01 Rosso, Valentina; Petiti, Jessica; Bracco, Enrico; Pedrola, Roberto; Carnuccio, Francesca; Signorino, Elisabetta; Carturan, Sonia; Calabrese, Chiara; Bot-Sartor, Giada; Ronconi, Michela; Serra, Anna; Saglio, Giuseppe; Frassoni, Francesco; Cilloni, Daniela
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
2013-01-01 Finazzi, Guido; Vannucchi, Alessandro M.; Martinelli, Vincenzo; Ruggeri, Marco; Nobile, Francesco; Specchia, Giorgina; Pogliani, Enrico Maria; Olimpieri, Odoardo Maria; Fioritoni, Giuseppe; Musolino, Caterina; Cilloni, Daniela; Sivera, Piera; Barosi, Giovanni; Finazzi, Maria Chiara; Tollo, Silvia Di; Demuth, Tim; Barbui, Tiziano; Rambaldi, Alessandro
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
2018-01-01 Santini Valeria, Allione Bernardino, Zini Gina, Gioia Daniela, Lunghi Monia, Poloni Antonella, Cilloni Daniela, Sanna Antonio, Masiera Elisa, Ceccarelli Mario, Abdel-Wahab Omar, Terenzi Adelmo,Angelucci E, Finelli Carlo, Onida Francesco, Pelizzari Annamaria, Ferrero Dario, Saglio Giuseppe, Figueroa Maria, Levis Alessandro.
A very sensitive and rapid method for BCR-ABL T315Imutation detection by peptide nucleic acid directed PCR clamping
2009-01-01 E. Bracco; M. Spagna; R. Pedrola; V. Rosso; F. Arruga; M. Lo Iacono; S. Carturan; F. Messa; C. Panuzzo; P. Nicoli; E. Messa; A. Rotolo; A. Morotti; S. Mussino; A. Balbo; D. Cilloni; S.G. Saglio
A young man with persistent eosinophilia
2007-01-01 MESSA E; CILLONI D; SAGLIO G
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.
2013-01-01 Cilloni D; Carturan S; Bracco E; Campia V; Rosso V; Torti D; Calabrese C; Gaidano V; Niparuck P; Favole A; Signorino E; Iacobucci I; Morano A; De Luca L; Musto P; Frassoni F; Saglio G.
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia
2005-01-01 SOVERINI S; MARTINELLI G; ROSTI G; BASSI S; AMABILE M; POERIO A; GIANNINI B; TRABACCHI E; CASTAGNETTI F; TESTONI N; LUATTI S; DE VIVO A; CILLONI D; IZZO B; FAVA M; ABRUZZESE E; ALBERTI D; PANE F; SAGLIO G; BACCARANI M.
Abl: the prototype of oncogenic fusion proteins
2004-01-01 G. SAGLIO; D. CILLONI
Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients
2012-01-01 Rosso V; Panuzzo C; Bracco E; Carturan S; Campia V; Favole A; Signorino E; Niparuk P; Calabrese C; De Luca L; Caivano A; Morano A; Frassoni F; Saglio G; Cilloni D
Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias
2005-01-01 Cilloni D; Bracco E; Defilippi I; Messa F; Carturan S; Di Giovanni D; Arruga F; Rosso V; Catalano R; Messa E; Morotti A; Serra A; Saglio G
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients
2006-01-01 IACOBUCCI I; SAGLIO G; ROSTI G; TESTONI N; PANE F; AMABILE M; POERIO A; SOVERINI S; BASSI S; CILLONI D; BASSAN R; BRECCIA M; LAURIA F; IZZO B; MERANTE S; FRASSONI F; PAOLINI S; MONTEFUSCO E; BACCARANI M; MARTINELLI G; GIMEMA WORKING; PARTY ON CHRONIC MYELOID LEUKEMIA
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
2012-01-01 S. Galimberti;F. Guerrini;F. Salvi;I. Petrini;D. Gioia;E. Messa;G. A. Palumbo;D. Cilloni;M. Petrini;A. Levis
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
2002-01-01 GUERRASIO A; PILATRINO C; DE MICHELI D; D. CILLONI; SERRA A; GOTTARDI E; PARZIALE A; MARMONT F; DIVERIO D; DIVONA M; LO COCO F; SAGLIO G.
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.
2013-01-01 Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G.
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
2020-01-01 Bertolotto A.; Martire S.; Mirabile L.; Capobianco M.; De Gobbi M.; Cilloni D.
Bcl-xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms
2020-01-01 Petiti J.; Lo Iacono M.; Rosso V.; Andreani G.; Jovanovski A.; Podesta M.; Lame D.; Gobbi M.D.; Fava C.; Saglio G.; Frassoni F.; Cilloni D.
Cardiovascular events and intensity of treatment in polycythemia vera
2013-01-01 Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T; CYTO-PV Collaborative Group
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536
2007-01-01 Morotti A; Parvis G; Cilloni D; Familiari U; Pautasso M; Bosa M; Messa F; Arruga F; Defilippi I; Catalano R; Rosso V; Carturan S; Bracco E; Guerrasio A; Saglio G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia | 2019 | Fava, Carmen; Berchialla, Paola; Petiti, Jessica; Bochicchio, Maria Teresa; Izzo, Barbara; Giugliano, Emilia; Ottaviani, Emanuela; Errichiello, Santa; Rege Cambrin, Giovanna; Venturi, Claudia; Luciano, Luigiana; Daraio, Filomena; Calistri, Daniele; Martino, Alessandro; Saglio, Giuseppe; Martinelli, Giovanni; Pane, Fabrizio; Cilloni, Daniela; Gottardi, Enrico Marco | |
| A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia | 2019 | Bernardoni, Roberto; Giordani, Giorgia; Signorino, Elisabetta; Monticelli, Sara; Messa, Francesca; Pradotto, Monica; Rosso, Valentina; Bracco, Enrico; Giangrande, Angela; Perini, Giovanni; Saglio, Giuseppe; Cilloni, Daniela | |
| A novel assay to detect calreticulin mutations in myeloproliferative neoplasms | 2017 | Rosso, Valentina; Petiti, Jessica; Bracco, Enrico; Pedrola, Roberto; Carnuccio, Francesca; Signorino, Elisabetta; Carturan, Sonia; Calabrese, Chiara; Bot-Sartor, Giada; Ronconi, Michela; Serra, Anna; Saglio, Giuseppe; Frassoni, Francesco; Cilloni, Daniela | |
| A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy | 2013 | Finazzi, Guido; Vannucchi, Alessandro M.; Martinelli, Vincenzo; Ruggeri, Marco; Nobile, Francesco; Specchia, Giorgina; Pogliani, Enrico Maria; Olimpieri, Odoardo Maria; Fioritoni, Giuseppe; Musolino, Caterina; Cilloni, Daniela; Sivera, Piera; Barosi, Giovanni; Finazzi, Maria Chiara; Tollo, Silvia Di; Demuth, Tim; Barbui, Tiziano; Rambaldi, Alessandro | |
| A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia | 2018 | Santini Valeria, Allione Bernardino, Zini Gina, Gioia Daniela, Lunghi Monia, Poloni Antonella, Cilloni Daniela, Sanna Antonio, Masiera Elisa, Ceccarelli Mario, Abdel-Wahab Omar, Terenzi Adelmo,Angelucci E, Finelli Carlo, Onida Francesco, Pelizzari Annamaria, Ferrero Dario, Saglio Giuseppe, Figueroa Maria, Levis Alessandro. | |
| A very sensitive and rapid method for BCR-ABL T315Imutation detection by peptide nucleic acid directed PCR clamping | 2009 | E. Bracco; M. Spagna; R. Pedrola; V. Rosso; F. Arruga; M. Lo Iacono; S. Carturan; F. Messa; C. Panuzzo; P. Nicoli; E. Messa; A. Rotolo; A. Morotti; S. Mussino; A. Balbo; D. Cilloni; S.G. Saglio | |
| A young man with persistent eosinophilia | 2007 | MESSA E; CILLONI D; SAGLIO G | |
| Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. | 2013 | Cilloni D; Carturan S; Bracco E; Campia V; Rosso V; Torti D; Calabrese C; Gaidano V; Niparuck P; Favole A; Signorino E; Iacobucci I; Morano A; De Luca L; Musto P; Frassoni F; Saglio G. | |
| ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia | 2005 | SOVERINI S; MARTINELLI G; ROSTI G; BASSI S; AMABILE M; POERIO A; GIANNINI B; TRABACCHI E; CASTAGNETTI F; TESTONI N; LUATTI S; DE VIVO A; CILLONI D; IZZO B; FAVA M; ABRUZZESE E; ALBERTI D; PANE F; SAGLIO G; BACCARANI M. | |
| Abl: the prototype of oncogenic fusion proteins | 2004 | G. SAGLIO; D. CILLONI | |
| Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients | 2012 | Rosso V; Panuzzo C; Bracco E; Carturan S; Campia V; Favole A; Signorino E; Niparuk P; Calabrese C; De Luca L; Caivano A; Morano A; Frassoni F; Saglio G; Cilloni D | |
| Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias | 2005 | Cilloni D; Bracco E; Defilippi I; Messa F; Carturan S; Di Giovanni D; Arruga F; Rosso V; Catalano R; Messa E; Morotti A; Serra A; Saglio G | |
| Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients | 2006 | IACOBUCCI I; SAGLIO G; ROSTI G; TESTONI N; PANE F; AMABILE M; POERIO A; SOVERINI S; BASSI S; CILLONI D; BASSAN R; BRECCIA M; LAURIA F; IZZO B; MERANTE S; FRASSONI F; PAOLINI S; MONTEFUSCO E; BACCARANI M; MARTINELLI G; GIMEMA WORKING; PARTY ON CHRONIC MYELOID LEUKEMIA | |
| Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. | 2012 | S. Galimberti;F. Guerrini;F. Salvi;I. Petrini;D. Gioia;E. Messa;G. A. Palumbo;D. Cilloni;M. Petrini;A. Levis | |
| Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. | 2002 | GUERRASIO A; PILATRINO C; DE MICHELI D; D. CILLONI; SERRA A; GOTTARDI E; PARZIALE A; MARMONT F; DIVERIO D; DIVONA M; LO COCO F; SAGLIO G. | |
| Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. | 2013 | Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G. | |
| Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients | 2020 | Bertolotto A.; Martire S.; Mirabile L.; Capobianco M.; De Gobbi M.; Cilloni D. | |
| Bcl-xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms | 2020 | Petiti J.; Lo Iacono M.; Rosso V.; Andreani G.; Jovanovski A.; Podesta M.; Lame D.; Gobbi M.D.; Fava C.; Saglio G.; Frassoni F.; Cilloni D. | |
| Cardiovascular events and intensity of treatment in polycythemia vera | 2013 | Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T; CYTO-PV Collaborative Group | |
| CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536 | 2007 | Morotti A; Parvis G; Cilloni D; Familiari U; Pautasso M; Bosa M; Messa F; Arruga F; Defilippi I; Catalano R; Rosso V; Carturan S; Bracco E; Guerrasio A; Saglio G. |